1. Home
  2. QMCO vs UNCY Comparison

QMCO vs UNCY Comparison

Compare QMCO & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Corporation

QMCO

Quantum Corporation

HOLD

Current Price

$13.74

Market Cap

129.1M

Sector

Technology

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$7.25

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QMCO
UNCY
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.1M
145.3M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
QMCO
UNCY
Price
$13.74
$7.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$10.50
$25.67
AVG Volume (30 Days)
1.4M
765.0K
Earning Date
02-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$372,827,000.00
$675,000.00
Revenue This Year
$0.32
N/A
Revenue Next Year
$8.35
$582.86
P/E Ratio
N/A
N/A
Revenue Growth
6.65
N/A
52 Week Low
$4.19
$3.72
52 Week High
$18.48
$8.74

Technical Indicators

Market Signals
Indicator
QMCO
UNCY
Relative Strength Index (RSI) 65.32 49.14
Support Level $5.98 $6.81
Resistance Level $15.33 $7.43
Average True Range (ATR) 2.04 0.58
MACD 0.14 0.00
Stochastic Oscillator 56.24 41.43

Price Performance

Historical Comparison
QMCO
UNCY

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: